Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

243.86
Delayed Data
As of Apr 28
 +0.81 / +0.33%
Today’s Change
184.50
Today|||52-Week Range
261.27
+16.12%
Year-to-Date
Weitz Value Fund Comments on Allergan
Apr 27 / GuruFocus News - Paid Partner Content
First Midwest Bank Trust Division Buys iShares Russell Mid-Cap, iShares Core S&P 500,...
Apr 26 / GuruFocus News - Paid Partner Content
Welch & Forbes Llc Buys Chubb, Check Point Software Technologies, Johnson Controls .....
Apr 27 / GuruFocus News - Paid Partner Content
Gamble Jones Investment Counsel Buys Vanguard Total Bond Market, Vanguard Short-Termo...
Apr 26 / GuruFocus News - Paid Partner Content
Healthy M&A Expected Following Trump's First 100 Days
Apr 27 / TheStreet.com - Paid Partner Content
Teva Confirms CFO Is Leaving
Apr 26 / TheStreet.com - Paid Partner Content
Whittier Trust Co Of Nevada Inc Buys Allergan PLC, Broadcom, EQT, Sells PIMCO Enhance...
Apr 27 / GuruFocus News - Paid Partner Content
Jerome Dodson Comments on Allergan
Apr 26 / GuruFocus News - Paid Partner Content
Braun Stacey Associates Inc Buys Incyte, KB Home, Pinnacle Foods, Sells Vulcan Materi...
Apr 26 / GuruFocus News - Paid Partner Content
Jerome Dodson's 1st Quarter Parnassus Fund Commentary
Apr 26 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close243.05
Today’s open243.09
Day’s range240.56 - 244.15
Volume1,835,243
Average volume (3 months)3,210,063
Market cap$81.8B
Dividend yield1.15%
Data as of 4:01pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.64%
Earnings growth (next 5 years)+11.90%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.61-1.98%
ABTAbbott Laboratories-0.01-0.02%
NVONovo Nordisk-0.10-0.26%
LLYEli Lilly and Co+0.73+0.90%
Data as of 4:03pm ET, 04/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$3.32
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts